Literature DB >> 21304240

Submucosal fibrosis and basic-fibroblast growth factor-positive neutrophils correlate with colonic stenosis in cases of ulcerative colitis.

Masaru Yamagata1, Tetuo Mikami, Tomoko Tsuruta, Kaoru Yokoyama, Miwa Sada, Kiyonori Kobayashi, Tomoe Katsumata, Wasaburou Koizumi, Katsunori Saigenji, Isao Okayasu.   

Abstract

BACKGROUND AND AIMS: The frequency of benign stenosis in ulcerative colitis (UC) is low, reported as being 3.2-11.2%, with fibrosis in the submucosa or deeper pointed out as one of the causes. The aim of the present study was to assess stenosis in UC cases using immunostaining and to analyze differences between stenotic and nonstenotic cases, focusing on basic-fibroblast growth factor (b-FGF) expression and myofibroblasts.
METHODS: Totals of 9 stenotic and 17 nonstenotic UC cases were histopathologically examined and immunohistochemically stained for b-FGF, α-smooth muscle actin (α-SMA), CD34, CD68 and IL-6. To identify b-FGF-positive cells, double immunostaining for b-FGF and myeloperoxidase or CD68 was performed.
RESULTS: In addition to submucosal fibrosis, a significant increase of b-FGF-positive inflammatory cells and myofibroblasts was observed in stenotic portions. Most b-FGF-positive cells were also positive for myeloperoxidase, and a correlation between b-FGF-positive and total neutrophil counts was found.
CONCLUSIONS: One of the major causes of stenosis in long-standing UC is fibrosis in the bowel wall, possibly induced by infiltrating inflammatory neutrophils producing b-FGF.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21304240     DOI: 10.1159/000320773

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  15 in total

1.  A Step Forward in the Understanding of Structural and Functional Bowel Damage in Patients with Ulcerative Colitis.

Authors:  Catarina Gouveia; Joana Torres
Journal:  GE Port J Gastroenterol       Date:  2017-11-08

2.  Colitic Cancer Develops Through Mutational Alteration Distinct from that in Sporadic Colorectal Cancer: A Comparative Analysis of Mutational Rates at Each Step.

Authors:  Toshiaki Tanaka; Takashi Kobunai; Yoko Yamamoto; Shigenobu Emoto; Koji Murono; Manabu Kaneko; Kazuhito Sasaki; Kensuke Otani; Takeshi Nishikawa; Kazushige Kawai; Keisuke Hata; Hiroaki Nozawa; Toshiaki Watanabe
Journal:  Cancer Genomics Proteomics       Date:  2017 Sep-Oct       Impact factor: 4.069

3.  The histopathological approach to inflammatory bowel disease: a practice guide.

Authors:  Cord Langner; Fernando Magro; Ann Driessen; Arzu Ensari; Gerassimos J Mantzaris; Vincenzo Villanacci; Gabriel Becheanu; Paula Borralho Nunes; Gieri Cathomas; Walter Fries; Anne Jouret-Mourin; Claudia Mescoli; Giovanni de Petris; Carlos A Rubio; Neil A Shepherd; Michael Vieth; Rami Eliakim; Karel Geboes
Journal:  Virchows Arch       Date:  2014-02-01       Impact factor: 4.064

Review 4.  Differential diagnosis in inflammatory bowel disease colitis: state of the art and future perspectives.

Authors:  Gian Eugenio Tontini; Maurizio Vecchi; Luca Pastorelli; Markus F Neurath; Helmut Neumann
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

5.  Paediatric Ulcerative Colitis Is a Fibrotic Disease and Is Linked with Chronicity of Inflammation.

Authors:  Ilyssa O Gordon; Suha Abushamma; Jacob A Kurowski; Stefan D Holubar; Lei Kou; Ruishen Lyu; Florian Rieder
Journal:  J Crohns Colitis       Date:  2022-06-24       Impact factor: 10.020

6.  Fibrosis in ulcerative colitis is directly linked to severity and chronicity of mucosal inflammation.

Authors:  I O Gordon; N Agrawal; E Willis; J R Goldblum; R Lopez; D Allende; X Liu; D Y Patil; L Yerian; F El-Khider; C Fiocchi; F Rieder
Journal:  Aliment Pharmacol Ther       Date:  2018-02-06       Impact factor: 8.171

7.  Ulcerative Colitis: Are We Neglecting Its Progressive Character.

Authors:  Paulo Massinha; Francisco Portela; Sara Campos; Gabriela Duque; Manuela Ferreira; Sofia Mendes; Ana Margarida Ferreira; Carlos Sofia; Luís Tomé
Journal:  GE Port J Gastroenterol       Date:  2017-10-20

Review 8.  Development of antifibrotic therapy for stricturing Crohn's disease: lessons from randomized trials in other fibrotic diseases.

Authors:  Si-Nan Lin; Ren Mao; Chenchen Qian; Dominik Bettenworth; Jie Wang; Jiannan Li; David H Bruining; Vipul Jairath; Brian G Feagan; Min-Hu Chen; Florian Rieder
Journal:  Physiol Rev       Date:  2021-09-27       Impact factor: 37.312

Review 9.  Revisiting fibrosis in inflammatory bowel disease: the gut thickens.

Authors:  Silvia D'Alessio; Federica Ungaro; Daniele Noviello; Sara Lovisa; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-12-07       Impact factor: 46.802

10.  An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis.

Authors:  Chiara Ippolito; Cristina Segnani; Mariella Errede; Daniela Virgintino; Rocchina Colucci; Matteo Fornai; Luca Antonioli; Corrado Blandizzi; Amelio Dolfi; Nunzia Bernardini
Journal:  J Cell Mol Med       Date:  2014-12-17       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.